U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
133681133681The Effect of Intranasal Administration of Oxytocin on Empathic Abilities.RecruitingNo Results AvailableSchizophreniaDrug: Oxytocin (also: syntocinon, pitocin)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00813436
133682133682Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to ChemotherapyActive, not recruitingNo Results AvailableAdult Solid NeoplasmDrug: Hydroxychloroquine|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Sunitinib Malatehttps://ClinicalTrials.gov/show/NCT00813423
133683133683Evaluation of a Novel Method for Integrating Insulin Delivery and Glucose Sensing in Adipose Tissue of Diabetic PatientsCompletedNo Results AvailableType 1 DiabetesProcedure: Glucose measurement at the sc. insulin delivery sitehttps://ClinicalTrials.gov/show/NCT00813410
133684133684Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.CompletedNo Results AvailableAdhesion PreventionDevice: Seprasprayhttps://ClinicalTrials.gov/show/NCT00813397
133685133685A Phase 1 Study of AMG 208 in Subjects With Advanced Solid TumorsCompletedNo Results AvailableCancer|Oncology|Tumors|Advanced Malignancy|Advanced Solid Tumors|Oncology PatientsDrug: AMG 208https://ClinicalTrials.gov/show/NCT00813384
133686133686Airway Pressure Release Ventilation as a Preventative StrategyWithdrawnNo Results AvailableAcute Respiratory Distress Syndrome|Acute Lung Injury|Respiratory Failure|TraumaDevice: Airway Pressure Release Ventilation|Device: ARDSnet protocolhttps://ClinicalTrials.gov/show/NCT00813371
133687133687Zenith TX2® Post-market Approval StudyActive, not recruitingNo Results AvailableDescending Thoracic Aortic AneurysmDevice: Zenith TX2® TAA Endovascular Grafthttps://ClinicalTrials.gov/show/NCT00813358
133688133688Ambulatory Anesthesia and Light TherapyRecruitingNo Results AvailableAnesthesia|ColonoscopyOther: light therapy (1500 lux)|Other: standard light (100 LUX)https://ClinicalTrials.gov/show/NCT00813345
133689133689Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)RecruitingNo Results AvailableAdvanced NSCLC|Recurrent NSCLCDrug: Endostar(rh recombinant endostatin) plus Docetaxel|Drug: Placebo plus Docetaxelhttps://ClinicalTrials.gov/show/NCT00813332
133690133690Girls OnGuard: HPV Vaccination Uptake Among African American Adolescent FemalesCompletedHas ResultsVaccinationBehavioral: Girls OnGuardhttps://ClinicalTrials.gov/show/NCT00813319
13369113369114473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter RelaxationsCompletedNo Results AvailableReflux EpisodesDrug: AZD2066|Drug: Placebo|Drug: AZD2066|Drug: AZD2066|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00813306
133692133692Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular CancerActive, not recruitingNo Results AvailableHepatocellular CancerDrug: Sorafenib|Procedure: Radiofrequency Ablationhttps://ClinicalTrials.gov/show/NCT00813293
133693133693Barriers to the Implementation of Complete Insulin Order SetsCompletedNo Results AvailableHyperglycemiahttps://ClinicalTrials.gov/show/NCT00813280
133694133694Mesenchymal Stem Cell for Osteonecrosis of the Femoral HeadActive, not recruitingNo Results AvailableOsteochondritis of the Femoral HeadBiological: mesenchymal stem cell infusion|Biological: bone marrow mononuclear cell infusionhttps://ClinicalTrials.gov/show/NCT00813267
133695133695Cost Utility Analysis in Recurrent Ovarian CancerWithdrawnNo Results AvailableOvarian CancerBehavioral: Questionnairehttps://ClinicalTrials.gov/show/NCT00813254
133696133696A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy VolunteersCompletedNo Results AvailableHealthy VolunteersDrug: celecoxib reference formulation|Drug: celecoxib test formulation A1|Drug: celecoxib test formulation B2|Drug: celecoxib test formulation C1https://ClinicalTrials.gov/show/NCT00813241
133697133697Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy IndividualsCompletedNo Results AvailableDiabetes Mellitus Type 1|Diabetes Mellitus Type 2Drug: Sitagliptin (Januvia)https://ClinicalTrials.gov/show/NCT00813228
133698133698Postprandial DysmetabolismActive, not recruitingNo Results AvailableType 2 Diabetes MellitusDietary Supplement: Meal challenge|Dietary Supplement: Meal challengehttps://ClinicalTrials.gov/show/NCT00813215
133699133699An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart FailureCompletedNo Results AvailableHeart Decompensation|Congestive Heart FailureDrug: Nesiritidehttps://ClinicalTrials.gov/show/NCT00813202
133700133700Efficacy Study of Recombinant Growth Hormone on Muscle Function in Children Long-term Treated With GlucocorticoidCompletedNo Results AvailableChronic Disease|Glucocorticoid Therapy, Response to|Growth RetardationDevice: GH treatmenthttps://ClinicalTrials.gov/show/NCT00813189
133701133701One-Lung Ventilation in the Morbidly Obese Patient: A Comparison of a Left-Sided Broncho-Cath® Double Lumen Tube With the Arndt® Wire-Guided BlockerCompletedNo Results AvailableObesityDevice: Double Lumen Endotracheal Tube|Device: Arndt Bronchial Blockerhttps://ClinicalTrials.gov/show/NCT00813176
133702133702Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic NeoplasmsDrug: PEP02https://ClinicalTrials.gov/show/NCT00813163
133703133703Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple MyelomaCompletedHas ResultsMultiple MyelomaDrug: Dexamethasone|Drug: Bortezomib|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00813150
133704133704FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal CancerRecruitingNo Results AvailableColorectal NeoplasmsDrug: Folfox4 plus recombinant human endostatin (Endostar)https://ClinicalTrials.gov/show/NCT00813137
133705133705Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)CompletedNo Results AvailableStem Cell Transplantation|LeukemiaDrug: Fludarabine|Drug: Busulfan|Drug: Thymoglobulin|Drug: Azacitidine|Procedure: Stem Cell Transplanthttps://ClinicalTrials.gov/show/NCT00813124
133706133706Phase 3 Study of Local Administration of SKY0402 for Postoperative Analgesia in Subject Undergoing Breast AugmentationTerminatedHas ResultsPainDrug: SKY0402|Drug: Bupivacaine HClhttps://ClinicalTrials.gov/show/NCT00813111
133707133707Study of LX1031 in Subjects With Non-Constipating Irritable Bowel SyndromeCompletedHas ResultsIrritable Bowel SyndromeDrug: LX1031 High Dose|Drug: LX1031 Low Dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00813098
133708133708A Randomized Trial of Electronic Integration of Care for Better Diabetes Outcomes; The COMPETE II StudyCompletedNo Results AvailableDiabetesOther: Electronic disease management decision supporthttps://ClinicalTrials.gov/show/NCT00813085
133709133709Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNo Results AvailableStomach Neoplasms|Esophageal NeoplasmsDrug: PEP02|Drug: irinotecan|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00813072
133710133710Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic NeuropathyRecruitingNo Results AvailableNon-arteritic Anterior Ischemic Optic NeuropathyDrug: Intra-vitreal injection of bevacizumab (1.25mg/0.05ml)https://ClinicalTrials.gov/show/NCT00813059

* Görseller ve İçerik tekif hakkına sahip olabilir